Praxis Precision Medicines, Inc. (PRAX)
285.81
-2.81
(-0.97%)
USD |
NASDAQ |
Oct 30, 16:00
289.00
+3.19
(+1.11%)
After-Hours: 20:00
Praxis Precision Medicines Free Cash Flow : -306.32M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -306.32M |
| March 31, 2026 | -282.53M |
| December 31, 2025 | -249.12M |
| September 30, 2025 | -228.82M |
| June 30, 2025 | -191.30M |
| March 31, 2025 | -163.88M |
| December 31, 2024 | -131.76M |
| September 30, 2024 | -98.45M |
| June 30, 2024 | -94.20M |
| March 31, 2024 | -98.16M |
| December 31, 2023 | -110.18M |
| September 30, 2023 | -115.10M |
| Date | Value |
|---|---|
| June 30, 2023 | -136.88M |
| March 31, 2023 | -162.91M |
| December 31, 2022 | -184.68M |
| September 30, 2022 | -201.29M |
| June 30, 2022 | -180.78M |
| March 31, 2022 | -153.67M |
| December 31, 2021 | -124.84M |
| September 30, 2021 | -99.70M |
| June 30, 2021 | -89.18M |
| March 31, 2021 | -69.07M |
| December 31, 2020 | -51.93M |
| September 30, 2020 | -41.67M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| BioMarin Pharmaceutical, Inc. | 725.08M |
| Insmed, Inc. | -- |
| Vertex Pharmaceuticals, Inc. | 3.796B |
| Ironwood Pharmaceuticals, Inc. | 185.55M |
| Xencor, Inc. | -208.28M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -77.19M |
| Cash from Investing (Quarterly) | 10.98M |
| Cash from Financing (Quarterly) | 4.224M |
| Free Cash Flow Per Share (Quarterly) | -2.685 |
| Free Cash Flow to Equity (Quarterly) | -77.86M |
| Free Cash Flow to Firm (Quarterly) | -78.21M |
| Free Cash Flow Yield | -4.07% |